Time to metastasis after prostatectomy (TTM) and survival outcomes in patients (pts) with metachronous metastatic hormone-sensitive prostate cancer (mHSPC): A secondary analysis of the SWOG 1216 phase 3 trial.

Authors: Nicolas Sayegh, Yeonjung Jo, Umang Swami, Chadi Hage Chehade, Zeynep Irem Ozay, Georges Gebrael, Benjamin L. Maughan, Melissa Plets, Maha H. A. Hussain, Tanya B. Dorff, Primo N Lara, Amir Goldkorn, Seth P. Lerner, Neeraj Agarwal

Published: 2025-02-18

DOI: 10.1200/jco.2025.43.5_suppl.173

Source: Full article

---

Abstract

173